Consistent with the former result that the liver function-related markers like AST, ALT, ALP, and GGT were upregulated in NAFLD patients (Table 1), there was a poor prognosis in NAFLD patient (Figure 2B). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.